Beijing Luzhu Biotechnology Co., Ltd.
Beijing Luzhu Biotechnology Co., Ltd.
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine | DNA Virus Infections, Herpesviridae infectious disease, Infections, Vaccine-Preventable Diseases, Varicella Zoster Virus Infection, herpes zoster, viral infectious disease | Recruiting | Phase 3 | 2023-10-18 | NCT06088745 |